Related references
Note: Only part of the references are listed.Cell cycle correlated genes dictate the prognostic power of breast cancer gene lists
Jonathan D. Mosley et al.
BMC MEDICAL GENOMICS (2008)
The properties of high-dimensional data spaces: implications for exploring gene and protein expression data
Robert Clarke et al.
NATURE REVIEWS CANCER (2008)
Microarrays: retracing steps
Kevin R. Coombes et al.
NATURE MEDICINE (2007)
Network-based classification of breast cancer metastasis
Han-Yu Chuang et al.
MOLECULAR SYSTEMS BIOLOGY (2007)
A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery
Jae K. Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor
Takashi Suzuki et al.
CANCER SCIENCE (2007)
The LeFE algorithm: embracing the complexity of gene expression in the interpretation of microarray data
Gabriel S. Eichler et al.
GENOME BIOLOGY (2007)
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)
[Anonymous]
LANCET ONCOLOGY (2007)
Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome
Vincent Vuaroqueaux et al.
BREAST CANCER RESEARCH (2007)
被撤回的出版物: Genomic signatures to guide the use of chemotherapeutics (Retracted article. See vol. 17, pg. 135, 2011)
Anil Potti et al.
NATURE MEDICINE (2006)
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
Marc Buyse et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Concordance among gene-expression-based predictors for breast cancer
Cheng Fan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Current concepts - Microarray analysis and tumor classification
John Quackenbush
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
M Colozza et al.
ANNALS OF ONCOLOGY (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Proliferation marker Ki-67 in early breast cancer
A Urruticoechea et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
LD Miller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
HY Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Outcome signature genes in breast cancer: is there a unique set?
L Ein-Dor et al.
BIOINFORMATICS (2005)
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
Y Pawitan et al.
BREAST CANCER RESEARCH (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prognostic value of proliferation in invasive breast cancer: a review
PJ van Diest et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Analysis of genomic and proteomic data using advanced literature mining
YH Hu et al.
JOURNAL OF PROTEOME RESEARCH (2003)
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer
H Kühling et al.
JOURNAL OF PATHOLOGY (2003)
E2F1 expression is related with the poor survival of lymph node-positive breast cancer patients treated with fluorouracil, doxorubicin and cyclophosphamide
S Han et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cyclin E and survival in patients with breast cancer.
K Keyomarsi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Diagnosis of multiple cancer types by shrunken centroids of gene expression
R Tibshirani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
